Cargando…

Effect of the 5-HT(2C) Receptor Agonist WAY-163909 on Serotonin and Dopamine Metabolism across the Rat Brain: A Quantitative and Qualitative Neurochemical Study

The effects triggered by serotonin2C (5-hydroxytryptamin(2C), 5-HT(2C)) receptor agonists in the brain are often subtle, and methodologies highlighting their widespread actions to account for their multiple modulatory influences on behaviors are still lacking. We report an extended analysis of a neu...

Descripción completa

Detalles Bibliográficos
Autores principales:	Whitestone, Sara, De Deurwaerdère, Philippe, Baassiri, Lynn, Manem, Julien, Anouar, Youssef, Di Giovanni, Giuseppe, Bharatiya, Rahul, Chagraoui, Abdeslam
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2019
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6627111/ https://www.ncbi.nlm.nih.gov/pubmed/31208016 http://dx.doi.org/10.3390/ijms20122925

Ejemplares similares

Lorcaserin Alters Serotonin and Noradrenaline Tissue Content and Their Interaction With Dopamine in the Rat Brain
por: Di Giovanni, Giuseppe, et al.
Publicado: (2020)

A Subset of Purposeless Oral Movements Triggered by Dopaminergic Agonists Is Modulated by 5-HT(2C) Receptors in Rats: Implication of the Subthalamic Nucleus
por: Lagière, Mélanie, et al.
Publicado: (2020)

New Insight into Selective Serotonin Receptor Agonists in the Central Nervous System, Studied with WAY163909 in Obese and Diabetic Wistar Rats
por: Bogomilov, Ivaylo, et al.
Publicado: (2023)

Imaging Evaluation of 5HT(2C) Agonists, [(11)C]WAY-163909 and [(11)C]Vabicaserin, Formed by Pictet–Spengler Cyclization
por: Neelamegam, Ramesh, et al.
Publicado: (2014)

Chronic Administration of Fipronil Heterogeneously Alters the Neurochemistry of Monoaminergic Systems in the Rat Brain
por: Bharatiya, Rahul, et al.
Publicado: (2020)

Dopamine D3 Receptor: Contemporary Views of Its Function and Pharmacology for Neuropsychiatric Diseases
por: De Deurwaerdère, Philippe, et al.
Publicado: (2021)

Editorial: Contemporary Perspective on 5-HT(2C) Receptor Function and Its Pharmacological Targeting
por: De Deurwaerdère, Philippe, et al.
Publicado: (2020)

L-DOPA in Parkinson’s Disease: Looking at the “False” Neurotransmitters and Their Meaning
por: Chagraoui, Abdeslam, et al.
Publicado: (2019)

Serotonin in Animal Cognition and Behavior
por: Bacqué-Cazenave, Julien, et al.
Publicado: (2020)

Cannabinoid 1/2 Receptor Activation Induces Strain-Dependent Behavioral and Neurochemical Changes in Genetic Absence Epilepsy Rats From Strasbourg and Non-epileptic Control Rats
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Neurobiological and Pharmacological Perspectives of D3 Receptors in Parkinson’s Disease
por: Chagraoui, Abdeslam, et al.
Publicado: (2022)

Editorial: New GPCR targets and modulators to treat CNS disorders
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Distribution and neurochemical characterization of neurons within the nucleus of the solitary tract responsive to serotonin agonist-induced hypophagia
por: Lam, Daniel D., et al.
Publicado: (2009)

Neurochemical specificity of learning: dopamine and motor learning.
por: McEntee, W. J., et al.
Publicado: (1987)

Serotonin in Health and Disease
por: De Deurwaerdère, Philippe, et al.
Publicado: (2020)

Role of prucalopride, a serotonin (5-HT(4)) receptor agonist, for the treatment of chronic constipation
por: Wong, Banny S, et al.
Publicado: (2010)

Crystal structure of the human 5-HT(1B) serotonin receptor bound to an inverse agonist
por: Yin, Wanchao, et al.
Publicado: (2018)

Brain Histamine Is Crucial for Selective Serotonin Reuptake Inhibitors‘ Behavioral and Neurochemical Effects
por: Munari, Leonardo, et al.
Publicado: (2015)

Pathophysiology of the Serotonin System in the Nervous System and Beyond
por: De Deurwaerdère, Philippe, et al.
Publicado: (2022)

Limiting Monoamines Degradation Increases L-DOPA Pro-Locomotor Action in Newborn Rats
por: Khsime, Inès, et al.
Publicado: (2023)

The neurochemical pathology of schizophrenia: post-mortem studies from dopamine to parvalbumin
por: Reynolds, Gavin P.
Publicado: (2021)

Effects of MDMA on Extracellular Dopamine and Serotonin Levels in Mice Lacking Dopamine and/or Serotonin Transporters
por: Hagino, Y, et al.
Publicado: (2011)

Anatomical relationships between serotonin 5-HT(2A) and dopamine D(2) receptors in living human brain
por: Ishii, Tatsuya, et al.
Publicado: (2017)

Lead-Induced Atypical Parkinsonism in Rats: Behavioral, Electrophysiological, and Neurochemical Evidence for a Role of Noradrenaline Depletion
por: Sabbar, Mariam, et al.
Publicado: (2018)

Repeated Clozapine Increases the Level of Serotonin 5-HT(1A)R Heterodimerization with 5-HT(2A) or Dopamine D(2) Receptors in the Mouse Cortex
por: Szlachta, Marta, et al.
Publicado: (2018)

Cardiac Roles of Serotonin (5-HT) and 5-HT-Receptors in Health and Disease
por: Neumann, Joachim, et al.
Publicado: (2023)

Correction: Anatomical relationships between serotonin 5-HT(2A) and dopamine D(2) receptors in living human brain
por: Ishii, Tatsuya, et al.
Publicado: (2018)

Altered 5-HT(2C )receptor agonist-induced responses and 5-HT(2C )receptor RNA editing in the amygdala of serotonin transporter knockout mice
por: Moya, Pablo R, et al.
Publicado: (2011)

Azologization of serotonin 5-HT(3) receptor antagonists
por: Rustler, Karin, et al.
Publicado: (2019)

Expression of Dopamine D(1−4) and Serotonin 5-HT(1A-3A) Receptors in Blood Mononuclear Cells in Schizophrenia
por: Wysokiński, Adam, et al.
Publicado: (2021)

Computational approaches for the design of novel dopamine D(2) and serotonin 5-HT(2A) receptor dual antagonist towards schizophrenia
por: Rathore, Akash, et al.
Publicado: (2022)

Serotonin homeostasis and serotonin receptors as actors of cortical construction: special attention to the 5-HT(3A) and 5-HT(6) receptor subtypes
por: Vitalis, Tania, et al.
Publicado: (2013)

Cre-ating Ways to Serotonin
por: Wisden, William
Publicado: (2010)

CENTRAL DOPAMINE AND SEROTONIN TURNOVER IN SCHIZOPHRENIA
por: Pandey, R.S., et al.
Publicado: (1987)

Increased dopamine release after working-memory updating training: Neurochemical correlates of transfer
por: Bäckman, Lars, et al.
Publicado: (2017)

Neurophysiological and Neurochemical Effects of the Putative Cognitive Enhancer (S)-CE-123 on Mesocorticolimbic Dopamine System
por: Sagheddu, Claudia, et al.
Publicado: (2020)

Dopamine agonist monotherapy utilization in patients with Parkinson’s disease
por: Frazer, Monica, et al.
Publicado: (2022)

The Mechanism and Pathways of Dopamine and Dopamine Agonists in Prolactinomas
por: Liu, Xiaoshuang, et al.
Publicado: (2019)

Development of a New Polymeric Nanocarrier Dedicated to Controlled Clozapine Delivery at the Dopamine D(2)-Serotonin 5-HT(1A) Heteromers
por: Łukasiewicz, Sylwia
Publicado: (2021)

N-Benzyl-5-methoxytryptamines as Potent Serotonin 5-HT(2) Receptor Family Agonists and Comparison with a Series of Phenethylamine Analogues
por: Nichols, David E., et al.
Publicado: (2014)

Cannot write session to /tmp/vufind_sessions/sess_66ch4hc19guhk1iepqqvpqgukp